TrialCardiovascular diabetology2020

Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial.

João Pedro Ferreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.